3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Melanoma
21
Brain Neoplasms
7
Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Pancreatic Neoplasms
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Hematologic Neoplasms
3
Thyroid Neoplasms
2
Lymphoma
2
Leukemia, Hairy Cell
2
Glioma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peripheral Nervous System Neoplasms
1
Interventions
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Noonan Syndrome 5
×
binimetinib
×
Clear all
NCT01885195
2021-02-21
SIGNATURE
Pfizer
Phase 2
Completed
110 enrolled
18 charts